Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

Differential 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET Responses to Pharmacologic Inhibition of the c-MET Receptor in Preclinical Tumor Models

Carleen Cullinane, Donna S. Dorow, Susan Jackson, Benjamin Solomon, Ekaterina Bogatyreva, David Binns, Richard Young, Maria E. Arango, James G. Christensen, Grant A. McArthur and Rodney J. Hicks
Journal of Nuclear Medicine August 2011, 52 (8) 1261-1267; DOI: https://doi.org/10.2967/jnumed.110.086967
Carleen Cullinane
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donna S. Dorow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Jackson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Solomon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ekaterina Bogatyreva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Binns
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Young
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria E. Arango
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James G. Christensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grant A. McArthur
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodney J. Hicks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 52 (8)
Journal of Nuclear Medicine
Vol. 52, Issue 8
August 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Differential 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET Responses to Pharmacologic Inhibition of the c-MET Receptor in Preclinical Tumor Models
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Differential 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET Responses to Pharmacologic Inhibition of the c-MET Receptor in Preclinical Tumor Models
Carleen Cullinane, Donna S. Dorow, Susan Jackson, Benjamin Solomon, Ekaterina Bogatyreva, David Binns, Richard Young, Maria E. Arango, James G. Christensen, Grant A. McArthur, Rodney J. Hicks
Journal of Nuclear Medicine Aug 2011, 52 (8) 1261-1267; DOI: 10.2967/jnumed.110.086967

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Differential 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET Responses to Pharmacologic Inhibition of the c-MET Receptor in Preclinical Tumor Models
Carleen Cullinane, Donna S. Dorow, Susan Jackson, Benjamin Solomon, Ekaterina Bogatyreva, David Binns, Richard Young, Maria E. Arango, James G. Christensen, Grant A. McArthur, Rodney J. Hicks
Journal of Nuclear Medicine Aug 2011, 52 (8) 1261-1267; DOI: 10.2967/jnumed.110.086967
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE STATEMENT
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • c-Met PET Imaging Detects Early-Stage Locoregional Recurrence of Basal-Like Breast Cancer
  • PET of c-Met in Cancer with 64Cu-Labeled Hepatocyte Growth Factor
  • Fluorodeoxyglucose-Based Positron Emission Tomography Imaging to Monitor Drug Responses in Solid Tumors
  • Fluorodeoxyglucose-Based Positron Emission Tomography Imaging to Monitor Drug Responses in Hematological Tumors
  • [18F]-FLT Positron Emission Tomography Can Be Used to Image the Response of Sensitive Tumors to PI3-Kinase Inhibition with the Novel Agent GDC-0941
  • Crizotinib for the Treatment of ALK-Rearranged Non-Small Cell Lung Cancer: A Success Story to Usher in the Second Decade of Molecular Targeted Therapy in Oncology
  • 3'-Deoxy-3'-18F-Fluorothymidine PET/CT to Guide Therapy with Epidermal Growth Factor Receptor Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire